MOSCOW (Reuters) - Russia took a step towards clamping down on the tobacco industry on Friday as a bill to ban smoking in public spaces and to restrict tobacco sales sailed through its first reading in parliament.
Modern Medicine Now
NEW YORK (Reuters Health) - Migraine patients have an increased risk of idiopathic sudden sensorineural hearing loss (SSNHL), a study from Taiwan suggests.
NEW YORK (Reuters Health) - Gastritis related to Helicobacter pylori infection is associated with a relatively small increased risk of colonic neoplasm, according to data from a large US database.
WASHINGTON (Reuters) - President Barack Obama says federal authorities should not target recreational marijuana use in two Western states where it has been made legal given limited government resources and growing public acceptance of the controlled substance.
LONDON (Reuters) - Nalmefene, a novel drug to fight alcohol dependency from Danish drugmaker Lundbeck, was given a green light by European regulators on Friday.
NEW YORK (Reuters Health) - Fish oil supplements may be ineffective against the chronic intestinal damage found in infants in developing regions, a new study suggests.
NEW YORK (Reuters Health) - The presence in plasma of sTREM-1 (soluble triggering receptor expressed on myeloid cells-1) had only "moderate" diagnostic performance in differentiating sepsis from systemic inflammatory response syndrome (SIRS) in a meta-analysis of relevant research.
NEW YORK (Reuters Health) - For patients with migraine and irritable bowel syndrome (IBS), an immunoglobulin G (IgG)-based food elimination diet may effectively reduce symptoms of both disorders, a small Turkish study suggests.
NEW YORK (Reuters Health) - The new phosphodiesterase type 5 (PDE5) inhibitor avanafil (Stendra) was safe and significantly more effective than placebo in reversing erectile dysfunction (ED) after bilateral nerve-sparing radical prostatectomy in a recent trial.